Moreover, the data of cutaneous melanoma from TCGA database indicated that low PARP4 expression was significantly related to shorter disease-free survival (DFS) (P = 0.037) and overall survival (OS) (P = 0.023) (Fig. 1D and E), indicating its significant role in the development and prognosis of melanoma. This evidence concerns the gene PARP4 and cutaneous melanoma.